The potent protein phosphatase 2A inhibitors aminocytostatins: new derivatives of cytostatin

J Antibiot (Tokyo). 2021 Oct;74(10):743-751. doi: 10.1038/s41429-021-00455-w. Epub 2021 Jul 21.

Abstract

Specific inhibitors of protein phosphatase 2A (PP2A) mediate anticancer effects by augmenting the tumor-killing activity of natural killer (NK) cells. In this study, new PP2A inhibitors, aminocytostatins A-E, were isolated from Kitasatospora sp. MJ654-NF4 and structurally characterized. Aminocytostatins are derivatives of cytostatin, which is a specific PP2A inhibitor isolated from the same organism, and aminocytostatins have a characteristic amino group within the lactone moiety. Compared to cytostatin, aminocytostatin A showed a stronger inhibitory activity against PP2A in vitro and augmented the tumor-killing activity of NK cells in vivo. Furthermore, a docking model was generated to demonstrate the favorable activities of aminocytostatin A.

MeSH terms

  • Animals
  • Antineoplastic Agents / chemistry*
  • Antineoplastic Agents / pharmacology*
  • Cell Line, Tumor
  • Cell Survival / drug effects
  • Drug Discovery
  • Mice
  • Molecular Docking Simulation
  • Molecular Structure
  • Organophosphates / chemistry*
  • Organophosphates / pharmacology*
  • Protein Binding
  • Protein Conformation
  • Protein Phosphatase 2 / antagonists & inhibitors*
  • Pyrones / chemistry*
  • Pyrones / pharmacology*
  • Streptomycetaceae / chemistry*
  • Structure-Activity Relationship

Substances

  • Antineoplastic Agents
  • Organophosphates
  • Pyrones
  • cytostatin
  • Protein Phosphatase 2